Position in ONC
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$223,986
-$7,056 QoQ
Shares Held
786
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 282 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BENJAMIN EDWARDS INC holds $15,258,994 across 15 Biotechnology names. ONC ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,025 | $5,476,447 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
54,488 | $2,971,774 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,613 | $1,629,310 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
80,881 | $1,368,506 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
31,009 | $1,064,228 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,841 | $720,629 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
168,540 | $618,540 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,168 | $351,603 |
All Filings in ONC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,986 | 786 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $231,042 | 778 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $209,628 | 690 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $217,707 | 639 | Shares | Defined | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||